Cargando…
Use of preservative-free hyaluronic acid (Hylabak(®)) for a range of patients with dry eye syndrome: experience in Russia
Artificial tear preparations are important in the management of dry eye syndrome. We present the findings from four recently published studies conducted in Russia assessing Hylabak(®) (marketed as Hyabak(®) in Europe), a preservative-free hyaluronic acid preparation, for the treatment of dry eye syn...
Autores principales: | Brjesky, Vladimir Vsevolodovich, Maychuk, Yury Fedorovich, Petrayevsky, Alexey Vladimirovich, Nagorsky, Peter Gerrievich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069143/ https://www.ncbi.nlm.nih.gov/pubmed/24970995 http://dx.doi.org/10.2147/OPTH.S47713 |
Ejemplares similares
-
Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK
por: Astakhov, Yuri S, et al.
Publicado: (2013) -
Crop production in Russia 2030: Alternative data of the development scenarios
por: Rudoy, Evgeny Vladimirovich, et al.
Publicado: (2020) -
Hyaluronic acid in the treatment of dry eye disease
por: Hynnekleiv, Leif, et al.
Publicado: (2022) -
Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease
por: Nasser, Linda, et al.
Publicado: (2018) -
The use of preservatives in dry eye drops
por: Walsh, Karen, et al.
Publicado: (2019)